Toward deep learning replacement of gadolinium in neuro-oncology: A review of contrast-enhanced synthetic MRI

Gadolinium-based contrast agents (GBCAs) have become a crucial part of MRI acquisitions in neuro-oncology for the detection, characterization and monitoring of brain tumors. However, contrast-enhanced (CE) acquisitions not only raise safety concerns, but also lead to patient discomfort, the need of...

Descripción completa

Detalles Bibliográficos
Autores principales: Moya-Sáez, Elisa, de Luis-García, Rodrigo, Alberola-López, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neuroimaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406200/
https://www.ncbi.nlm.nih.gov/pubmed/37554645
http://dx.doi.org/10.3389/fnimg.2023.1055463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406200/
https://www.ncbi.nlm.nih.gov/pubmed/37554645
http://dx.doi.org/10.3389/fnimg.2023.1055463

Ejemplares similares